Public page captured October 22, 2026. Promotional sheets and temporary interface overlays were dismissed or removed in the static reference. No personal or medical information was entered. Captured entry screens do not reproduce the complete consultation.

Visual reference: Creator · start on Ro, snack in hand. The main campaign sends price, medication-launch, creator and celebrity ads to one Serena-led entrance. A treatment-format question sits in the hero; choosing Learn about both reveals a weight-goal question without leaving the page. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
The nugget is the hook. Josh opens holding one up under the card "Start on GLP-1s on Ro" and asks if viewers think starting is complicated, which pairs a funny visual with the objection Ro wants to answer. He then pokes at a stereotype people recognize (the guy who orders grilled chicken with no dressing) and says he still enjoys his favorite foods without obsessing over his next meal. That's a specific moment of use, told in his voice, and the on-screen text attributes the average weight-loss figure to a study with a results-may-vary note.
Josh makes it sound easy, but the ad doesn't show what easy looks like, so the claim that it's all online stays abstract. There's also no cost cue or reason to act now beyond his closing line about having nothing to lose. If you make one like this, keep the food-in-hand open and cut once to the actual first screen viewers will see, then end on a specific step (like how long the questions take), so the joke leads somewhere concrete.
A funny, unexpected prop earns the first second while the caption names the objection.
Mocking a stereotype makes the viewer feel seen and lowers resistance.
His own experience gives the claim a person behind it, and the disclaimer qualifies the numbers.
It turns the story into a next step and lists the reasons to trust Ro.
No price. Josh invites viewers to see if they qualify, framed as low-risk with his line about having nothing to lose.
The ad sends people to Ro's quiz entry page, the strongest rung of the landing-page ladder because the first question starts a personal assessment. That fits Josh's promise that getting started isn't complicated: the page asks one thing (pill, shot, both, or a provider recommendation) and nothing else. The celebrity swap is noticeable, though, since Josh's playful tone gives way to a polished Serena Williams hero. A line on the page that echoes his simple-to-start point would make the hand-off feel deliberate. It's one of 71 ads in the Fluid library landing here.
Ro's main weight-loss landing page is a quiz entry: Serena Williams, labeled as a Ro member, stands beside a card asking which GLP-1 option you want. It's the destination for 71 Ro ads in the Fluid library, mostly price-led statics, Serena creator videos and pill-versus-pen product stills, nearly all ending on See if you qualify.
A pale yellow strip claims the lowest prices for GLP-1s are on Ro, the page's only answer to 'is this affordable?'
Lose weight on Ro names the category and the brand, so the visitor knows they're in the right place before reading anything else.
Serena holds a pen-style product with a Ro member label and a product thumbnail beside her, answering 'is this the thing from the ad?'
A white card asks which Ro option you're interested in (pill, shot, learn about both, or a provider recommendation), which starts the quiz and sorts visitors by how far along they are.
After Learn about both, the same card asks how much weight you're looking to lose in ranges plus Not sure yet, keeping the visitor on the page while the quiz continues.
Legal, terms, privacy and consumer health data privacy links sit beside a LegitScript Certified badge, answering 'is this a legitimate pharmacy?' for anyone who scrolls.
Read the full breakdown of this page
One of 100 Ro ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.